Hiroki Yamaguchi Selected Research

Hiroki Yamaguchi Research Topics

Disease

17	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 09/2023 - 11/2008
10	Neoplasms (Cancer) 04/2024 - 08/2006
9	Aplastic Anemia (Anemia, Hypoplastic) 05/2024 - 08/2003
7	Hematologic Neoplasms (Hematological Malignancy) 09/2023 - 10/2010
6	Leukemia 03/2024 - 12/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2023 - 01/2012
5	Infections 01/2021 - 12/2010
4	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2023 - 09/2010
4	Fever (Fevers) 01/2022 - 12/2003
4	Human Influenza (Influenza) 10/2021 - 12/2003
4	Renal Insufficiency (Renal Failure) 01/2021 - 03/2003
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2021 - 01/2016
4	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021 - 08/2003
4	Hemorrhage 11/2019 - 12/2004
3	Lymphoma (Lymphomas) 02/2023 - 07/2006
3	Acute Kidney Injury (Acute Renal Failure) 09/2022 - 03/2003
3	Heart Failure 01/2022 - 01/2016
3	Febrile Neutropenia 11/2020 - 09/2010
3	Thrombotic Microangiopathies 03/2020 - 09/2011
3	Chronic Renal Insufficiency 03/2020 - 01/2019
3	Hyperalgesia 01/2017 - 10/2016
3	Bone Marrow Failure Disorders 03/2008 - 08/2003
2	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 03/2023 - 01/2009
2	Anemia 01/2023 - 11/2018
2	Ischemia 01/2023 - 06/2004
2	Hypotension (Low Blood Pressure) 01/2023 - 09/2022
2	Amyloidosis 08/2022 - 01/2022
2	Hypoglycemia (Reactive Hypoglycemia) 08/2022 - 01/2021
2	Transthyretin-Related Hereditary Amyloidosis 08/2022 - 01/2022
2	COVID-19 08/2022 - 02/2022
2	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2022 - 01/2013
2	Thyroiditis 06/2022 - 04/2021
2	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 04/2021
2	Headache (Headaches) 01/2022 - 11/2018
2	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022 - 02/2010
2	Type 2 Diabetes Mellitus (MODY) 04/2021 - 01/2021
2	Aneurysm (Aneurysms) 09/2020 - 01/2020
2	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 06/2020 - 11/2003
2	Atrial Fibrillation 01/2020 - 12/2017
2	Genetic Translocation (Chromosomal Translocation) 01/2018 - 09/2011
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2017 - 09/2011
2	Respiratory Insufficiency (Respiratory Failure) 01/2016 - 07/2013
1	Esophageal Neoplasms (Esophageal Cancer) 04/2024
1	Esophageal Squamous Cell Carcinoma 04/2024

Drug/Important Bio-Agent (IBA)

6	Tyrosine Kinase InhibitorsIBA 05/2023 - 09/2011
6	telomerase RNA (bTR)IBA 06/2020 - 08/2003
5	CytokinesIBA 10/2023 - 06/2004
4	EnzymesIBA 03/2024 - 03/2008
4	Messenger RNA (mRNA)IBA 03/2024 - 01/2002
4	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 02/2010
4	Proteins (Proteins, Gene)FDA Link 01/2022 - 03/2008
4	Telomerase (Telomerase Reverse Transcriptase)IBA 06/2020 - 04/2005
4	Rituximab (Mabthera)FDA Link 01/2013 - 02/2010
3	Cytarabine (Cytosar-U)FDA LinkGeneric 02/2023 - 11/2008
3	ReninIBA 01/2023 - 03/2022
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2022 - 12/2007
3	Therapeutic UsesIBA 01/2022 - 12/2003
3	laninamivirIBA 10/2021 - 04/2013
3	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2021 - 12/2007
3	Phosphotransferases (Kinase)IBA 11/2019 - 01/2018
3	Core Binding Factors (Core-Binding Factor)IBA 10/2017 - 11/2008
3	Analgesics (Analgesic Drugs)IBA 01/2017 - 10/2016
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2014 - 11/2008
3	Anti-Bacterial Agents (Antibiotics)IBA 12/2012 - 12/2003
3	RNA (Ribonucleic Acid)IBA 02/2010 - 04/2005
2	Etoposide (VP 16)FDA LinkGeneric 02/2023 - 11/2008
2	AldosteroneIBA 01/2023 - 03/2022
2	CCAAT-Enhancer-Binding Protein-alphaIBA 11/2022 - 01/2016
2	Prealbumin (Transthyretin)IBA 08/2022 - 01/2022
2	fms-Like Tyrosine Kinase 3IBA 01/2022 - 06/2009
2	HLA Antigens (Human Leukocyte Antigens)IBA 04/2021 - 01/2016
2	AntibodiesIBA 04/2021 - 01/2021
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 02/2010
2	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 01/2021 - 12/2007
2	Clopidogrel (Plavix)FDA Link 01/2021 - 10/2014
2	DEET (DET)IBA 11/2020 - 10/2020
2	Dasatinib (BMS 354825)FDA Link 03/2020 - 01/2012
2	NucleophosminIBA 10/2018 - 01/2016
2	Neuraminidase (Sialidase)IBA 09/2018 - 04/2013
2	QuinolonesIBA 12/2013 - 12/2010
2	Imatinib Mesylate (Gleevec)FDA Link 01/2012 - 11/2006
2	fludarabineIBA 10/2010 - 12/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2004 - 06/2004
2	EndotoxinsIBA 06/2004 - 03/2003
1	MicroRNAs (MicroRNA)IBA 04/2024
1	MycotoxinsIBA 04/2024

Therapy/Procedure

19	Therapeutics 03/2024 - 06/2006
13	Hematopoietic Stem Cell Transplantation 05/2024 - 09/2011
10	Transplantation 02/2023 - 12/2007
9	Drug Therapy (Chemotherapy) 09/2023 - 12/2002
4	Stem Cell Transplantation 01/2021 - 12/2007
3	Extracorporeal Membrane Oxygenation 11/2019 - 07/2013
3	Cell Transplantation 11/2018 - 12/2007
3	Cardiopulmonary Bypass (Heart-Lung Bypass) 07/2013 - 08/2006
2	Endovascular Aneurysm Repair 01/2023 - 01/2020
2	Renal Dialysis (Hemodialysis) 09/2022 - 11/2019
2	Induction Chemotherapy 11/2020 - 01/2002
2	Maze Procedure 01/2020 - 12/2017
2	Sternotomy 11/2019 - 09/2018
2	Catheters 10/2015 - 12/2004